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Abstract Background: Little is
known about the role of HSV-1 in
keratitis not primarily attributed to
herpetic origin. This study therefore
aimed to prospectively evaluate the
corneal explant buttons of patients
with non-herpetic or clinically atypi-
cal herpetic stromal keratitis (experi-
mental group: non-HSK) for the
presence of HSV-1 antigens and
DNA, and to compare the findings
with those from individuals with typ-
ical herpetic stromal keratitis (posi-
tive control group: HSK) or non-
inflammatory degenerative kera-
topathy (negative control group).
Methods: Corneal buttons derived
from 51 patients with HSK, from 72
with non-HSK and from 30 with de-
generative keratopathy were pro-
spectively collected and subjected to
immunohistochemical analysis for
HSV-1 antigens and to HSV-1 DNA
amplification. Results: In corneal
buttons derived from patients with
non-HSK, viral antigens were detect-
ed immunohistochemically in 8/72
cases and DNA amplified in 16/72.
Corresponding values for the HSK
group were 16/51 and 11/51. Taking
viral antigen and DNA findings to-
gether, HSV-1 was detected in 18/72
(25%) patients with non-HSK and in
19/51 (37%) with HSK (p=0.2), but
in only 2/30 (6%) individuals with
non-inflammatory degenerative kera-
topathy. Conclusion: Since the de-
tection frequencies for HSV-1 anti-
gens and DNA were comparable in
the HSK and non-HSK groups, 
Herpes may play an underestimated
and as yet undefined role in non-
herpetic and clinically atypical her-
petic stromal keratitis, either as a 
primary trigger of the disease or as a
secondary contributor to it. In this
category of individuals, early anti-
herpetic therapy should be consid-
ered if patients do not respond in the
expected manner to treatment for
non-herpetic stromal keratitis.
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Introduction
According to accepted concepts, recurrences of herpetic
stromal disease are triggered by the reactivation of latent
virus within the trigeminal ganglion or its periphery, this
event being followed by transneuronal spread to the cor-
nea [11, 26]. Nevertheless, viral DNA has been detected
within the cornea even when there exists no evidence of
active or previous clinical disease [32]. The possibility
of corneal viral latency [9, 28, 33] and of persisting rep-
licativity at various peripheral sites [34, 43], including
the cornea [13], has added to the complexity of the pic-
ture without shedding further light on the disease mecha-
nisms.
In cases of active stromal keratitis, replication has
been localized to the corneal stroma by the direct elec-
tron-microscopic demonstration of complete viral parti-
cles therein [11]. It has been speculated that the presence
of viral particles within the cornea triggers a specific 
local immune response which, in the initial phase, is 
directed against the virus itself [16, 38, 44]. At a later
stage of the disease, and in chronic or recurrent inflam-
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mation, keratitis is more likely to result from an im-
munopathological process triggered by neutrophils and
orchestrated by CD4-positive T-lymphocytes [25]. It re-
mains a matter of debate whether a failing autoimmuno-
regulation underlies this process or whether the inflam-
matory activity is redirected in targeting as yet undefined
cross-reactive but common antigenic epitopes of HSV-1
within stromal structures [3], thereby inducing a stromal
autoreactive process [40, 45]. By this means, the inflam-
matory process would become independent of viral repli-
cation.
In humans, primary ocular HSV-1 infection is not un-
usually subclinical [31], whereas the course followed by
chronic and recurrent keratitis depends heavily upon the
extent of stromal involvement, neovascularization and
cicatrization [20].
Both amplification of HSV-1 DNA by polymerase
chain reaction (PCR) and the immunohistochemical lo-
calization of viral antigens have proved to be sensitive
means of detecting HSV-1 activity [21]. Accordingly, the
aetiologic diagnosis of viral diseases such as necrotizing
herpetic retinopathies may be established in up to 90%
of cases by analysing samples of aqueous humour [14].
In instances of recurrent stromal keratitis, however, nei-
ther antigen detection nor the amplification of viral DNA
by PCR has proved to be sufficiently sensitive [16, 19,
37]. The fact that even highly sensitive techniques have
consistently failed to confirm the aetiology in cases of
herpetic stromal keratitis may be accounted for by one of
three hypotheses. It is possible, of course, that the clini-
cal diagnosis is false. Alternatively, the replication of
HSV-1 could lie below the level of detection. On the 
other hand, the low copy numbers of viral antigen and
DNA could have been destroyed by local protease and
DNAse activity. In this case, HSV-1 would play a subor-
dinate role at the time of clinical diagnosis, but would
nevertheless be capable of initiating a T-cell-directed im-
munopathological response even in the later absence of
viral replication. This latter theory is currently gaining
credence amongst virologists and immunologists in the
field [33, 40].
We still have no clear conception of the manner in
which HSV-1 drives herpetic keratitis. Viral replication
probably takes place predominantly within the corneal
epithelium, whilst the inflammatory reaction is ex-
pressed almost exclusively within the underlying stroma
[40]. The enigma lies in the circumstance that viral repli-
cation is a prerequisite for the induction of inflammation
[2].
HSV-1 has been reported to be present within both in-
flamed and clinically healthy corneal tissue [32], thereby
raising doubt as to the clinical relevance of its detection.
In the present study, we attempted to define the role of
HSV-1 in cases that were not clinically attributable to
this virus or not unambiguously so. This category of in-
dividuals was referred to as the non-herpetic stromal ker-
atitis (non-HSK) group. Findings relating to the detec-
tion rates of HSV-1 antigens and DNA in this non-HSK
group were compared to those in individuals with either
clinically typical herpetic stromal keratitis (HSK group;
positive control) or non-inflammatory degenerative kera-
topathy (negative control).
Materials and methods
A total of 153 corneal buttons were obtained from patients undergo-
ing keratoplasty. Of these, 51 had clinically typical HSK [group 1
(positive control): HSK] and 72 had stromal keratitis which was not
clinically attributable to HSV-1 or not unambiguously so [group 2
(experimental): non-HSK]; the other 30 had non-inflammatory de-
generative keratopathy [group 3 (negative control)]. Corneal buttons
were included in groups 1 or 2 irrespective of the level of disease
activity. Our justification for this is that viral antigens and/or DNA
presumably persist in the cornea for a lifetime, thus rendering their
detection independent of disease activity. This concept of long-term
persistence and latency of viral antigens and DNA within corneal
tissue has only recently been reinforced [5, 7, 9, 12, 35]. Until now,
there has existed no evidence for an association between the detec-
tion rates of viral DNA and/or antigens and clinical disease activity.
Nevertheless, the vast majority of patients in groups 1 and 2 did not
manifest marked inflammatory activity at the time of corneal trans-
plantation.
Experimental and control groups
Group 1 (positive control), HSK. The diagnosis of HSK was estab-
lished if a systemic granulomatous disease condition had been
ruled out anamnestically in individuals with four or more of the
eight criteria listed in Table 1. The anamnestic exclusion of sys-
temic granulomatous disease was targeted to rule out ocular in-
volvement in untreated or insufficiently treated cases of mycobac-
terial, sarcoidotic or syphilitic disease, which might lead indepen-
dently to an unsatisfactory postoperative course.
Group 2 (experimental), non-HSK. The diagnosis of a non-herpetic
disease condition was established in cases of stromal keratitis that
did not meet the inclusion criteria for group 1, i.e. in patients
whose clinical picture was not typically herpetic, and in those
whose condition had been proved to be of other origin (Table 2).
Table 1 Diagnostic criteria for
HSK History of recurrent stromal keratitisHistory, or documented episodes, of dendritic epithelial keratitis
Recurrent disciform keratitis with endothelial precipitates
Recurrent interstitial keratitis with deep stromal vascularization or acute stromal necrosis
Corneal hypaesthesia
Post-inflammatory sectorial atrophy of the iris after sectorial granulomatous iritis
Secondary glaucoma
Documented response to combined systemic Acyclovir and local steroid treatment in the past
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Group 3 (negative control), degenerative keratopathy. Cases of 
established degenerative corneal disease with no clinical evidence
of an active or previous corneal inflammatory episode (Table 3).
Since no generally accepted set of criteria exists for an un-
equivocal differentiation between each and every clinical entity,
the distinguishing features summarized in Tables 1, 2 and 3 are
based upon our own clinical experience. Accordingly, clinically
typical cases of herpetic keratitis (group 1) are separated from the
broad experimental category (group 2) embracing all other forms
of inflammatory keratitis, including possibly atypical HSK, and
from the negative control group, which includes all non-inflamma-
tory forms of keratopathy (group 3). For a differentiation on this
basis, all patients with corneal disease attributable to trauma,
chemical burning or an unknown cause had to be excluded [15].
Collection of corneal buttons
Excised corneal buttons were tranisected through the scarred re-
gion, immediately fixed in buffered 4% formaldehyde solution for
24 h and then embedded in paraffin. Tissue sections 30 µm thick
were prepared and used for DNA extraction and amplification, as
described in detail elsewhere [14]. Briefly, DNA was liberated by
digesting the tissue in 100 µl of proteinase K buffer for 30 min at
60°C and for 10 min at 95°C [13, 18]. After centrifugation, 5 µl of
the supernatant were withdrawn and either used immediately for
the amplification assay or stored at −20°C for future analysis.
From the second half of the scarred corneal button, an approxi-
mately 100-µg sample was excised and incubated in 200 µl of pro-
teinase K buffer as described above. After centrifugation (10,000 g
for 10 min), the supernatant was withdrawn and either used imme-
diately for DNA amplification or stored at −20°C for future analy-
sis [13].
Methods for the detection of HSV-1 DNA or antigens
DNA amplification and hybridization. The amplification proce-
dure has been fully described elsewhere [13]; only the pertinent
details are given here. DNA amplification was run under standard
conditions. Primers were directed against the glycoprotein D gene
(amplification fragment length: 221 base pairs [1]) and the thymi-
dine kinase gene (amplification fragment length: 110 base pairs
[23]). Carryover was prevented by a pre-amplification cleavage
with uracil N-glycosylase [22] and by incorporating uracil triphos-
phates into the amplificates. All buffers and media used were rou-
tinely run as internal negative controls to exclude the possibility of
viral contamination. Internal controls for specificity included cul-
ture supernatants from cells infected with HSV-1, HSV-2, varicel-
la-zoster virus or cytomegalovirus. In each amplification experi-
ment, positive internal controls containing 10 ng of an HSV-1
DNA equivalent, consisting of approximately 10 viral copies
(fragment length: 221 base pairs), were also included. Each posi-
tive result was confirmed by an independent control amplification.
Negative samples were sporadically spiked with minute amounts
of control HSV-1 DNA and run in separate PCRs to detect false
negatives attributable to the presence of inhibitory factors. A tis-
sue was deemed to harbour HSV-1 DNA if this was amplified
from one of the two samples of fresh or paraffinized tissue.
Immunohistochemistry. Sections of paraffin-embedded corneal tis-
sue 6 µm thick were transferred to SuperFrost slides (Wetzel
Glasses, Mainz, Germany), dewaxed and rehydrated. They were
then incubated at ambient temperature with primary rabbit-anti-
HSV-1 (B 0114, DAKO Diagnostics Ltd., Cambridgeshire, UK;
diluted 1:200 in Tris-chloride buffer, pH 7.2), the antibody then
being detected according to the streptavidin/biotin method (in
compliance with the manufacturer’s instructions; LSAB-2 kit,
DAKO Diagnostics, Cambridgeshire, UK).
Positive and negative internal controls consisted of a pair of
donor corneas that failed to meet our transplantation criteria. One
of the corneas, maintained in minimal essential medium, served as
the negative control, whilst its partner, infected in vitro with a
clinical HSV-1 isolate, served as the positive control. These con-
trols were always run in parallel so as to be able to define the 
signal/noise amplitude. The evaluation was conducted according
to a standard protocol, the investigator being kept in ignorance of
information pertaining to patients. To assess specificity, we also
evaluated the distribution and cell-association of positive signals.
In the event of high background staining or the inability to inter-
pret a given result, a second experiment was run using a higher 
dilution of the antibody (1:1000 instead of 1:200).
Statistical analysis
Data were analysed using the “Statistica for Windows” program,
version 5.1 (StatSoft, Inc., Tulsa, Okla., USA), the χ2 test being
employed for comparisons between two groups and the maximum-
likelihood χ2 test for those involving all three. Statistical signifi-
cance was set at a p value of <0.05.
Results
Immunohistological staining of corneal explant tissue re-
vealed the presence of HSV-1 antigens in 8 (11%) of the
72 buttons excised from patients with non-HSK, in 16
(31%) of the 51 buttons derived from individuals with
HSK (χ2 test: p=0.01), and in 1 (3%) of the 30 taken
from subjects with non-inflammatory degenerative kera-
Table 2 Diagnostic criteria for
non-HSK Inflammatory corneal disease that fails to meet the criteria for herpetic keratitis, i.e.Scar after interstitial or parenchymatous keratitis without recurrences
Keratitis in systemic rheumatic and autoimmune disease
Viral keratitis of proven non-herpetic (i.e. varicella-zoster) origin
Proven bacterial or mycotic keratitis without recurrence
Excluded: Scarring induced by trauma or chemical burns
Table 3 Diagnostic criteria for
non-inflammatory degenerative
keratopathy
Keratoconus
Simple or secondary endothelial atrophy
Corneal dystrophies (i.e. Fuchs’ dystrophy)
Excluded: Scarring induced by trauma, chemical burns or unknown factors
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topathy. The analysis for HSV-1 DNA yielded corre-
sponding numbers of 16/72 (22%), 11/51 (22%; χ2 test:
p=0.97) and 1/30 (3%; χ2 test: p=0.06).
Taking these findings together, HSV-1 antigens and or
DNA were detected in 18 (25%) of the 72 buttons ex-
cised from patients with non-HSK, in 19 (37%) of the 51
buttons derived from individuals with HSK (χ2 test:
p=0.20), and in 2 (7%) of the 30 buttons taken from sub-
jects with non-inflammatory degenerative keratopathy
(χ2 test: p=0.01) (Table 4).
Discussion
In this study, we evaluated corneal explant tissue im-
munohistochemically for the presence of HSV-1 antigens
(against glycoprotein D) and for that of HSV-1 DNA by
amplification and hybridization. By these means, we at-
tempted to define the role of HSV-1 in the pathogenesis
of non-HSK at the time of corneal transplantation.
Clinical signs and symptoms represent the sole estab-
lished basis for diagnosing HSK, which, for some elu-
sive reason, cannot be confirmed by laboratory testing
in the majority of cases, despite important therapeutic
consequences. Although the clinical signs and symp-
toms are deemed to be characteristic (Table 1), our data
indicate that they are unable to differentiate clearly be-
tween HSK and non-HSK at the time of corneal trans-
plantation. There exists a substantial body of evidence
indicating that many cases of HSK are either overlooked
or diagnosed late, which is a disquieting circumstance.
In concrete terms, the fact that HSV-1 was detected in
only 37% of the samples derived from patients with ac-
tive HSK implies that the detection sensitivity was like-
wise 37%. On this basis, the 25% detection level re-
vealed for the non-HSK group represents an underesti-
mation of the HSV-1 contribution, the truer value lying
around 60%.
It should also be borne in mind that the majority of
patients had undergone long-term, multidrug anti-inflam-
matory treatment for previous and current disease states
prior to corneal surgery. This circumstance will inevita-
bly modify the clinical as well as the histological picture
of the disease and might thereby influence the interpreta-
tion of the clinical situation and reduce the predictive
value of the immunohistochemical evaluation. Indeed,
the immunohistochemical analysis confirmed the pres-
ence of HSV-1 in less than one third of the cases with
HSK. In tissue evincing little to moderate inflammation,
the HSV-1 antigen is readily detected, but when chronic
stromal infiltration and vascularization are manifest, the
signal is often masked by intense non-specific back-
ground straining. Although the severe inflammatory re-
action may be partially attributable to previous treat-
ment, the immunohistochemical mapping of HSV-1 is
nonetheless known to yield highly variable results [2,
16].
In cases of active herpetic uveitis and keratouveitis,
our own aqueous humour analyses have led us to the 
realization that antigen degradation (possibly by mono-
nuclear cells [10, 30]) or neutralization is responsible for
a marked attenuation in detection sensitivity with in-
creasing time after the onset of inflammation [37]. The
existence of such a relationship has been demonstrated
experimentally [2], but not in a clinical setting. HSV-1
DNA is known to be more resistant to enzymatic degra-
dation than HSV-1 antigens in the corneal environment
[2], which explains the twofold higher detection rate for
HSV-1 DNA.
Although a positive amplification signal proves the
local presence of HSV-1, it does not necessarily follow
that the virus contributes to the clinical disease [29].
Added to this uncertainty, we have no conception of how
the presence of viral DNA in clinically healthy corneal
tissue [5, 8, 14, 27, 32] is to be understood. The possibil-
ity of contamination has, of course, to be considered. But
several independent laboratories, each with a long-stand-
ing reputation in DNA amplification, and each taking the
utmost precautions to prevent the carryover of amplifica-
tion products, have obtained identical results in this re-
spect [6, 14, 24, 42]. We are thus forced to conclude that
the presence of HSV-1 DNA in the human cornea may
be harmless or even physiological. However, the mecha-
nism underlying its tolerance, as well as its possible
physiological function, have yet to be defined, and the
possibility of its playing a hazardous role after the trans-
plantation of infected corneal tissue also remains to be
clarified [5, 36, 41].
In conclusion, a high proportion of cases with non-
herpetic or clinically atypical stromal keratitis (non-HSK
group) harboured HSV-1 antigens or DNA, the clinical
relevance of which remains to be clarified. On the other
hand, the applied case-definition criteria for HSK, al-
though generally acceptable, are perhaps too stringent, in
Table 4 Analysis of corneal
explant buttons Detection of HSK Non-HSK p value HSK/ Degenerative keratopathy(n=51) (n=72) non-HSK (n=30)
Antigen (Ag) 16/51 (31%) 8/72 (11%) 0.01 1/30 (3%)
DNA 11/51 (22%) 16/72 (22%) 0.97 1/30(3%)
Ag and DNA 8/51 (16%) 6/72 (8%) 0.32 1/30 (3%)
Ag and/or DNA* 19/51 (37%) 18/72 (25%) 0.20 2/30 (7%)*p=0.01 (HSK vs non-HSK vsdegenerative keratopathy)
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that a substantial number of individuals with ambiguous
clinical signs and symptoms are excluded and assigned
to the non-HSK group. Therefore in cases of non-HSK
which do not respond in the expected manner to treat-
ment for a non-herpetic condition, it may be expedient to
instigate supplementary anti-herpetic and immunomodu-
latory therapy.
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